Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements of Operations (Unaudited)

v2.4.0.8
Condensed Statements of Operations (Unaudited) (USD $)
3 Months Ended 6 Months Ended
Jun. 30, 2014
Jun. 30, 2013
Jun. 30, 2014
Jun. 30, 2013
Revenues:        
Product revenues $ 1,154,569 $ 497,373 $ 1,867,828 $ 957,626
Development service revenues 4,984 65,116 103,846 219,062
Other service revenues 29,351   39,761  
Related party license revenues       650,000
Total revenues 1,188,904 562,489 2,011,435 1,826,688
Cost of product revenues 576,935 295,777 927,620 522,108
Research and development costs 898,423 741,817 1,716,044 1,513,270
Selling, general, and administrative expenses 1,929,134 1,703,191 3,729,933 3,336,638
Gain on sale of intellectual property     (4,338,601)  
Operating loss (2,215,588) (2,178,296) (23,561) (3,545,328)
Other income (expense):        
Gain on change in fair value of deriviative liabilities 875,546 955,271 1,359,336 2,578,969
Loss on note payable modification       (1,356,177)
Other income (expense), net 25,993 (6,945) 129,379 367,388
Interest income 4,644 7,771 7,251 14,890
Interest expense (283,695) (129,733) (435,103) (235,422)
Net income (loss) $ (1,593,100) $ (1,351,932) $ 1,037,302 $ (2,175,680)
Net income (loss) per share attributable to common stockholders:        
Basic (in Dollars per share) $ (0.03) $ (0.02) $ 0.02 $ (0.04)
Diluted (in Dollars per share) $ (0.03) $ (0.02) $ 0.02 $ (0.04)
Weighted average shares outstanding:        
Basic (in Shares) 58,919,945 57,384,247 58,817,350 56,129,908
Diluted (in Shares) 58,919,945 57,384,247 60,602,643 56,129,908